Learn more

GUANGDONG JINCHENG JINSU PHARMACEUTICAL CO LTD

Overview
  • Total Patents
    11
  • GoodIP Patent Rank
    160,179
  • Filing trend
    ⇧ 66.0%
About

GUANGDONG JINCHENG JINSU PHARMACEUTICAL CO LTD has a total of 11 patent applications. It increased the IP activity by 66.0%. Its first patent ever was published in 2017. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are GLADE ORGANICS PRIVATE LTD, METABRAIN RES and BIOMARIN IGA LTD.

Patent filings in countries

World map showing GUANGDONG JINCHENG JINSU PHARMACEUTICAL CO LTDs patent filings in countries
# Country Total Patents
#1 China 11

Patent filings per year

Chart showing GUANGDONG JINCHENG JINSU PHARMACEUTICAL CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wu Fengzhe 7
#2 Fu Miaoqing 7
#3 Li Qiurong 6
#4 Zhu Xuwei 6
#5 Ma Qingshuang 6
#6 Zhou Baishui 5
#7 Yi Maocong 5
#8 Ying Peng 4
#9 Yu Yuping 3
#10 Huang Jialing 2

Latest patents

Publication Filing date Title
CN110684066A Cytophosphocholine medicinal preparation and new application thereof in cerebral infarction acute-stage disturbance of consciousness
CN110684038A New indication of pharmaceutical preparation of troxofen ceftriaxone sodium for treating pelvic inflammation
CN110396102A Cefoxitin sodium pharmaceutical preparation is in vaginal hysterectomy, abdominal cavity uterectomy, the preoperative prevention infection application of (palace) production of cutting open the belly
CN110396101A Qu Suofen Ceftriaxone Sodium pharmaceutical preparation treats the new indication of bacillary intimitis
CN110396103A Cefazolin sodium or combinations thereof object, preparation method and its preparation and genital system infection new indication
CN110396105A Mei Fu elder generation cefoxitin sodium pharmaceutical preparation prevents infection application in gastrointestinal surgery
CN110393720A Qu Suofen Ceftriaxone Sodium pharmaceutical preparation treats the new indication of immunity function immunocompromised patients infection
CN110393719A The new indication of cefoperazone sodium sulbactam sodium pharmaceutical preparation treatment infectious endocarditis
CN107693491A A kind of children use C15H16N7NaO5S3Pharmaceutical entities composition and preparation
CN107028951A A kind of children use C19H17N6NaO6S2Pharmaceutical entities composition and preparation
CN107080749A A kind of children use C13H11N8O4NaS3Pharmaceutical entities composition and preparation